Thymalin

Immune / Bioregulatory Peptideapproved (Russia)

Also known as: Thymus extract, Thymaline

A thymic peptide bioregulator developed in Russia that restores immune function by promoting T-cell maturation and has shown anti-aging effects in clinical studies on elderly patients.

Overview

Thymalin is a polypeptide complex originally isolated from calf thymus glands, developed by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology in Russia. It belongs to a class of compounds called peptide bioregulators — short peptides that regulate gene expression in specific tissues. Thymalin targets the thymus gland and immune system, promoting T-cell differentiation, restoring immune function in immunocompromised individuals, and normalizing immune biomarkers. In landmark Russian clinical studies spanning decades, Thymalin (often combined with Epithalon) was shown to reduce mortality and improve health outcomes in elderly populations. The thymus undergoes significant involution with aging, and Thymalin is theorized to partially reverse this decline, restoring thymic output of naive T-cells. While widely used in Russian and Eastern European medicine, Thymalin has limited recognition in Western medical literature.

Mechanism of Action

Thymalin acts on the immune system through multiple pathways: (1) Promotes maturation and differentiation of T-lymphocytes in the thymus; (2) Restores the balance between T-helper and T-suppressor cell populations; (3) Enhances phagocytic activity of macrophages and neutrophils; (4) Stimulates production of thymic hormones including thymulin; (5) Modulates cytokine production, normalizing inflammatory responses; (6) May partially reverse age-related thymic involution; (7) Regulates neuroendocrine-immune interactions.

Molecular Formula

Complex mixture of thymic peptides

Molecular Weight

< 10,000 Da

Sequence

Complex mixture — primary active peptides include EW (Glu-Trp) dipeptide

Dosage Protocols

Dose Range

5mg10mg

Frequency

Once daily

Route

intramuscular

Cycle Length

5-10 days per course, 1-2 courses per year

Standard Russian clinical protocol. Reconstitute in saline. Courses are typically given in spring and autumn. Often combined with Epithalon for synergistic anti-aging effects.

Source: Russian clinical protocols (Khavinson Institute)

Side Effects

EffectSeverity
Injection site painmild
Allergic reactionmoderate
Mild fevermild
Fatiguemild

Pros & Cons

Decades of clinical use in Russia with published mortality-reduction data in elderly populations

Addresses the root cause of immunosenescence — thymic involution

Short treatment courses (5-10 days) with effects lasting months

Synergistic with Epithalon for comprehensive anti-aging protocols

Most clinical evidence comes from Russian studies that may not meet Western RCT standards

Not FDA-approved and unfamiliar to most Western physicians

Animal-derived product with potential batch variability

Limited availability of high-quality product outside Russia

Research Studies

Legal Status

Approved pharmaceutical in Russia and some CIS countries. Not FDA-approved. Available as a research peptide in Western countries. No specific regulatory restrictions as a research compound.

Related Peptides